The solution is all about access and making it easier for folks to access food.
Annie Kuster
The Public Record
Annie L. McLane Kuster is an American politician serving as the U.S. Representative for New Hampshire's 2nd congressional district since January 3, 2013. A member of the Democratic Party, Kuster has focused on issues such as healthcare, women's rights, and economic development throughout her tenure in Congress. She has been an advocate for expanding access to affordable healthcare and has worked on initiatives to support small businesses in her district.
This is no way for Americans to be living in the 21st century. And we need bold leadership at the EPA to clean up these contaminated sites and safeguard the American people.
Today I rise in strong support of the American Rescue Plan Act, ambitious and urgently needed legislation to end the COVID-19 epidemic and to facilitate our economic recovery. The Federal Government has a responsibility to provide support…
One area where we know the EPA must take quick action is addressing PFAS and other forever chemicals.
I am so grateful for this discussion to highlight these measures and provide a framework as we look ahead to expanding access to care through telehealth post-COVID-19.
It is very frustrating in 2021 that so many Americans don't have access to that necessary technology.
Today, I rise in strong support of the American Rescue Plan Act, bold and desperately needed legislation to crush the COVID-19 pandemic and bolster our economic recovery. As our Nation mourns over 500,000 Americans who have lost their…
I believe that the Federal Government must take bold action to invest in clean energy to achieve net-zero carbon emissions because it is good for our health, it is good for the planet, and it will create millions of good-paying green jobs.
I believe we should also pursue negative-emission technologies that remove carbon directly from the atmosphere.
Across the United States, Americans are finally seeing the administration of COVID-19 vaccines improve after a slow rollout. The development of two highly effective vaccines in under 1 year is an unprecedented scientific accomplishment…
we need a coordinated approach between the Federal Government and the States.
Knowing ahead of time how much they can expect to receive will be incredibly helpful.